WallStSmart

Chemed Corp (CHE)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 599% more annual revenue ($17.76B vs $2.54B). CHE leads profitability with a 10.2% profit margin vs 8.6%. UHS appears more attractively valued with a PEG of 1.02. UHS earns a higher WallStSmart Score of 70/100 (B).

CHE

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 7.5Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: 5.69

UHS

Strong Buy

70

out of 100

Grade: B

Growth: 6.7Profit: 7.0Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHE.

UHSSignificantly Overvalued (-29.7%)

Margin of Safety

-29.7%

Fair Value

$178.30

Current Price

$145.17

$33.13 premium

UndervaluedFair: $178.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHE3 strengths · Avg: 9.7/10
Return on EquityProfitability
30.6%10/10

Every $100 of equity generates 31 in profit

Altman Z-ScoreHealth
5.6910/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

UHS3 strengths · Avg: 9.7/10
P/E RatioValuation
6.1x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Return on EquityProfitability
20.2%9/10

Every $100 of equity generates 20 in profit

Areas to Watch

CHE4 concerns · Avg: 3.3/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-0.4%2/10

Earnings declined 0.4%

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : CHE

The strongest argument for CHE centers on Return on Equity, Altman Z-Score, Debt/Equity.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.02 suggests the stock is reasonably priced for its growth.

Bear Case : CHE

The primary concerns for CHE are PEG Ratio, Revenue Growth, Piotroski F-Score.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

UHS carries more volatility with a beta of 1.08 — expect wider price swings.

UHS is growing revenue faster at 9.6% — sustainability is the question.

UHS generates stronger free cash flow (184M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UHS scores higher overall (70/100 vs 51/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chemed Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Chemed Corporation provides hospice and hospice services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers across the United States. The company is headquartered in Cincinnati, Ohio.

Visit Website →

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?